Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model
Carolyn Waugh Kinkade(Columbia University), Cory Abate‐Shen(Johnson University)
Cited by 387
Related Papers
Molecular genetics of prostate cancer: new prospects for old challenges
|Genes & Development|2010|951
Molecular genetics of prostate cancer
|Genes & Development|2000|733
Genetically Engineered Mouse Models of Prostate Cancer in the Postgenomic Era
|Cold Spring Harbor Perspectives in Medicine|2018|54